Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D4.5/L13: medical device reports filed with FDA

916 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

916
device reports naming the brand
0% of all MAUDE reports · about 131 a year
70
reports, 12 months to August 2026
117 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 916 reports that name the brand "XiVE S plus Impl D4.5/L13" (implant endosseous root-form), received between July 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

70 reports arrived in the 12 months to August 2026, down 40% from 117 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (37%), osseointegration problem (34.7%) and loss of osseointegration (27.2%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01835Sep 2021: 6Oct 2021: 14Nov 2021: 11Dec 2021: 72022Jan 2022: 35Feb 2022: 17Mar 2022: 11Apr 2022: 11May 2022: 16Jun 2022: 18Jul 2022: 17Aug 2022: 21Sep 2022: 11Oct 2022: 8Nov 2022: 10Dec 2022: 132023Jan 2023: 15Feb 2023: 20Mar 2023: 14Apr 2023: 11May 2023: 22Jun 2023: 15Jul 2023: 21Aug 2023: 10Sep 2023: 14Oct 2023: 11Nov 2023: 14Dec 2023: 72024Jan 2024: 16Feb 2024: 8Mar 2024: 5Apr 2024: 15May 2024: 14Jun 2024: 11Jul 2024: 13Aug 2024: 22Sep 2024: 10Oct 2024: 18Nov 2024: 8Dec 2024: 82025Jan 2025: 11Feb 2025: 11Mar 2025: 17Apr 2025: 6May 2025: 9Jun 2025: 3Jul 2025: 9Aug 2025: 7Sep 2025: 12Oct 2025: 7Nov 2025: 6Dec 2025: 12026Jan 2026: 4Feb 2026: 8Mar 2026: 8Apr 2026: 2May 2026: 4Jun 2026: 8Jul 2026: 5Aug 2026: 5

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01222442019: 1920192021: 24420212022: 18820222023: 17420232024: 14820242025: 9920252026: 442026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%916
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%916
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate33937%62.8%
Osseointegration problem31834.7%7.7%
Loss of osseointegration24927.2%22.4%
Fracturea broken bone80.9%1.6%
Damaged thread20.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant91599.9%
Inflammationinflammation13514.7%
Osteolysis616.7%
Pocket erosion444.8%
Painpain, site not specified20.2%
Deformity/ disfigurement10.1%
Discomfortdiscomfort10.1%
Fistula10.1%
Inadequate osseointegration10.1%
Low oxygen saturation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D4.5/L13Product code DZEAll MAUDE reports
Reports9163,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D4.5/L13 reports

How many FDA reports name XiVE S plus Impl D4.5/L13?

916 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 70 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (37%), osseointegration problem (34.7%), loss of osseointegration (27.2%), fracture (0.9%) and damaged thread (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D4.5/L13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.